Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,248,358
  • Shares Outstanding, K 189,471
  • Annual Sales, $ 2,759 M
  • Annual Income, $ -1,029 M
  • EBIT $ -220 M
  • EBITDA $ 864 M
  • 60-Month Beta 1.42
  • Price/Sales 6.99
  • Price/Cash Flow 18.08
  • Price/Book 7.71

Options Overview Details

View History
  • Implied Volatility 8.22% (+0.11%)
  • Historical Volatility 73.99%
  • IV Percentile 6%
  • IV Rank 2.51%
  • IV High 76.81% on 08/01/25
  • IV Low 6.45% on 12/08/25
  • Expected Move (DTE 22) 1.81 (1.78%)
  • Put/Call Vol Ratio 0.10
  • Today's Volume 67
  • Volume Avg (30-Day) 1,160
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 61,066
  • Open Int (30-Day) 61,898
  • Expected Range 99.73 to 103.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 4
  • High Estimate 0.20
  • Low Estimate -0.23
  • Prior Year -0.06
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
100.95 +0.58%
on 12/08/25
102.66 -1.09%
on 12/19/25
+0.53 (+0.52%)
since 11/24/25
3-Month
52.39 +93.82%
on 09/25/25
102.66 -1.09%
on 12/19/25
+48.42 (+91.15%)
since 09/24/25
52-Week
38.81 +161.62%
on 08/07/25
102.66 -1.09%
on 12/19/25
+43.43 (+74.74%)
since 12/24/24

Most Recent Stories

More News
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics has outperformed the broader healthcare sector over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.

XLV : 155.80 (+0.52%)
DGX : 175.92 (+0.48%)
EXAS : 101.54 (-0.05%)
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS

New data reveals Oncodetect’s powerful prognostic performance in one of the largest TNBC MRD studies to date 1

EXAS : 101.54 (-0.05%)
1 Healthcare Stock for Long-Term Investors and 2 We Avoid

1 Healthcare Stock for Long-Term Investors and 2 We Avoid

EXAS : 101.54 (-0.05%)
ALHC : 19.15 (-1.95%)
ALGN : 157.84 (+0.69%)
3 Overrated Stocks That Concern Us

3 Overrated Stocks That Concern Us

MOV : 20.71 (+0.44%)
EXAS : 101.54 (-0.05%)
NEO : 12.30 (-0.97%)
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

SEMR : 11.85 (-0.08%)
MRSN : 29.10 (+0.34%)
EXAS : 101.54 (-0.05%)
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN

NEW YORK , Nov. 27, 2025 / PRNewswire/ --

SEE : 41.36 (+0.27%)
MRSN : 29.10 (+0.34%)
EXAS : 101.54 (-0.05%)
CDTX : 220.86 (unch)
Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

BLFY : 12.74 (-0.16%)
GDOT : 13.08 (+0.46%)
EXAS : 101.54 (-0.05%)
Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium

First clinical validation of the Oncodetect ® test to be presented in triple negative breast cancer; signals highly sensitive molecular residual disease (MRD) detection ...

EXAS : 101.54 (-0.05%)
Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks

Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks

EXAS : 101.54 (-0.05%)
Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Exact Sciences ...

ABT : 124.81 (+0.22%)
EXAS : 101.54 (-0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 101.79
2nd Resistance Point 101.72
1st Resistance Point 101.63
Last Price 101.54
1st Support Level 101.47
2nd Support Level 101.40
3rd Support Level 101.31

See More

52-Week High 102.66
Last Price 101.54
Fibonacci 61.8% 78.27
Fibonacci 50% 70.74
Fibonacci 38.2% 63.20
52-Week Low 38.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar